Unlocking New Horizons in Proteostasis: Strategic Advance...

2026-01-20

Explore the mechanistic landscape and strategic applications of MG-262 (Z-Leu-Leu-Leu-B(OH)2), a potent, reversible, and cell-permeable proteasome inhibitor. This thought-leadership article integrates recent advances in muscle proteostasis, translational disease modeling, and experimental design—delivering actionable insights for researchers at the intersection of proteasome inhibition, cell cycle regulation, and autophagy.